What is uniMIND?
uniMIND aims to set up academic discussion groups that meet and talk about psychedelic science. Students and senior academics of any level and any background engage in a critical discourse on altered states of consciousness and psychedelics. The discussion revolves around their application in basic and clinical research, the brain sciences, philosophy, and human development.
International psychedelic science is regaining momentum in dozens of universities. Current research findings show that psychedelics can be effective therapeutic agents in the treatment of mental conditions such as depression, anxiety, addiction, and trauma. Besides their effect in treating mental disorders, psychedelics are shown to promote creativity, productivity, and wellbeing in supporting contexts. MDMA and psilocybin are currently in clinical trials for the treatment of post-traumatic stress disorder and treatment-resistant depression, respectively.
uniMIND groups meet regularly at a convenient location. One person gets to present a publication/topic/project per meeting using e.g. slides, handouts, or an oral presentation. Topics may cover any discipline of psychedelic science, from psychotherapy and neuroscience to anthropology and social science. The topic has to be shared prior to the meeting, to allow the rest of the group to prepare.
Ultimately, uniMIND aspires to initiate dialogue about psychedelic science that educates and inspires. It can be the starting point for writing bachelor, master and doctoral thesis, collaboration for project application, and building risk-aware and vivid communities.